This inventor holds 1 USPTO granted patent. Top assignee: City University of Hong Kong. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Bill Kwan-wai Chan: Innovator in Antibiotic Resistance Treatment
Introduction
Bill Kwan-wai Chan is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of medicine, particularly in the treatment of antibiotic-resistant infections. His work focuses on innovative methods and compositions that address critical health challenges.
Latest Patents
One of Chan's key patents is titled "Methods and compositions for treating carbapenem-resistant Klebsiella pneumoniae infections." This patent outlines methods of using rifampicin and zidovudine, along with pharmaceutical compositions that inhibit the growth of and/or kill antibiotic-resistant bacteria. This invention is crucial in the ongoing battle against antibiotic resistance.
Career Highlights
Chan is affiliated with the City University of Hong Kong, where he contributes to research and development in the medical field. His work has garnered attention for its potential impact on public health, particularly in treating infections that are resistant to conventional antibiotics.
Collaborations
Chan has collaborated with esteemed colleagues such as Sheng Chen and Hongyuhang Ni. These partnerships enhance the research efforts and broaden the scope of innovation in their shared field.
Conclusion
Bill Kwan-wai Chan's contributions to antibiotic resistance treatment exemplify the importance of innovation in healthcare. His work not only addresses immediate medical challenges but also paves the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile